Form 8-K TG THERAPEUTICS, INC. For: Aug 10

Go back to Form 8-K TG THERAPEUTICS, INC. For: Aug 10

TG Therapeutics (TGTX) Continuing to Drive on All Cylinders; Roth Affirms 'Focus Pick' Rating

August 10, 2015 11:27 AM EDT

Roth Capital reaffirms TG Therapeutics, Inc. (Nasdaq: TGTX) with a Focus Pick rating and $33 price target following... More

TG Therapeutics (TGTX) Misses Q2 EPS by 8c

August 10, 2015 9:14 AM EDT

TG Therapeutics (NASDAQ: TGTX) reported Q2 EPS of ($0.38), $0.08 worse than the analyst estimate of ($0.30).

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

... More